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Abstract— Electronic health records (EHR) contain a large
variety of information on the clinical history of patients such as
vital signs, demographics, diagnostic codes and imaging data.
The enormous potential for discovery in this rich dataset is
hampered by its complexity and heterogeneity.
We present the first study to assess unsupervised homoge-
nization pipelines designed for EHR clustering. To identify the
optimal pipeline, we tested accuracy on simulated data with
varying amounts of redundancy, heterogeneity, and missingness.
We identified two optimal pipelines: 1) Multiple Imputation
by Chained Equations (MICE) combined with Local Linear
Embedding; and 2) MICE, Z-scoring, and Deep Autoencoders.
I. INTRODUCTION
Doctors provide diagnoses to help predict the health
trajectory of their patients. A diagnosis also helps to predict
what treatments have the highest likelihood of improving a
patients health. The more granular the diagnosis, the more
specific or “precise” medicine can become. The wealth of
medical data gathered from patients, that is digitally avail-
able in an electronic health record (EHR), should support
highly granular diagnoses. Unfortunately, the current clinical
paradigm of a human physician wading through this vast sea
of data cannot deliver the promise of precision medicine.
Fortunately, advances in machine learning can be har-
nessed to sift through this rich dataset and extract useful in-
formation to facilitate human decisions. One popular applica-
tion is phenotyping by cluster analysis. Previous studies [1],
[2], [3] have shown that clustering algorithms have the
potential to classify patients into similar phenotypes based
on data contained in the medical record. For example, using
unbiased hierarchical cluster analysis and penalized model-
based clustering, Shah et al. [2] identified 3 phenotypes in
patients diagnosed with heart failure with preserved ejection
fraction. Upon identification of such granular and more
homogeneous clusters, the outcomes (e.g. hospitalization,
cardiac events or mortality) and attempted therapies within
each cluster can then be linked together to predict likely
outcomes resulting from choosing particular therapies.
While there have been many advances in the field of
cluster analysis [4], the methods rely on the assumption of
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homogeneous, non-redundant and complete data. However,
EHR data are heterogeneous (variables can be continuous
or categorical, and with different scales), redundant (multi-
ple measurements may assess the same underlying patient
feature), incomplete (many fields in the clinical reports are
sparsely filled depending on the purpose of the study), and
noisy (not all variables are informative in all conditions).
Additionally, human errors and system biases also contribute
to measurement errors in EHR data. Thus, to fully utilize
the EHR to reliably detect disease subtypes, clustering tech-
niques must be paired with pre-processing techniques that
normalize and reduce the complexity of the raw EHR data.
Such a clustering pipeline, including pre-processing steps,
has not been previously proposed or validated.
In this paper, we assess and propose an optimal clustering
pipeline that is robust to the nuisances of EHR data. The
pipeline consists of imputation, normalization, feature re-
duction, and clustering. Multiple commonly used techniques
are evaluated at each step, and the best performing pipeline
is selected. Since the accuracy of clusters in real EHR
applications cannot be measured due to lack of a ground
truth, we assessed accuracy using simulated EHR data where
ground truth could be easily defined. To the best of our
knowledge, this is the first study to propose and validate an
unsupervised homogenization pipeline for EHR clustering.
II. METHODS
A. EHR Data Simulation
We simulated patient encounters with a sample genera-
tor that mimics the redundancy and heterogeneity of EHR
data. We defined rows for patient encounters (samples) and
columns for measurements taken from the patient (features).
We designed three clusters with n samples per cluster,
observed dimensionality m, and effective dimensionality of
2 (for visualization convenience).
The sample generator drew 3n independent samples from
a multivariate normal distribution with µ = [0, 0], and
Σ = I2×2 to form the matrix N3n×2. Then, we separated
the clusters by shifting n samples at a time. The first n
samples stayed in the origin, while the next n were shifted
by [d, 0], and the last n were shifted by [d2 ,
√
3
2 d], forming
an equilateral triangle with a distance d from each vertex.
We emulated redundancy by projecting the original feature
vector to a m-dimensional space: X3n×m = N3n×2P2×m,
where the elements of the projection matrix, P , were drawn
from a uniform distribution in the range (0, 1).
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Fig. 1: Missingness experiment results.
We then enforced heterogeneity by quantizing half of the
variables (set to zero if below the mean and 1 otherwise),
chosen at random, and scaling each continuous feature with
a random factor between 1 and 100. Finally, we added
Gaussian noise (µ = 0, σ = 1) to every element in the data
matrix to mimic measurement errors.
B. EHR Clustering Pipeline
1) Imputation: We tested median imputation, where the
median value from valid samples complete missing values;
k-Nearest Neighbors (KNN), where the average value from
the k-nearest samples is used; and Multiple Imputation by
Chained Equations (MICE) [5], where the missing values are
predicted based on regression models with complete samples.
2) Normalization: For continuous variables, we tested Z-
score, where every variable is set to zero mean and unit
variance; MinMax, which normalizes to a [0,1] range; and
Whitening, where the feature space is linearly projected such
that inter-feature covariance is the identity matrix.
3) Feature reduction: We propose the use of Deep
Autoencoders (DAE) [6] and Denoising Autoencoders
(DnAE) [7] for EHR feature reduction. Autoencoders are
trained to reconstruct an input through encoding and de-
coding networks. In the DnAE case, noise is added to the
encoded units to enforce robustness to measurement noise.
We designed the network architechture with a hyper-
parameter search for layers, hidden, and encoding units.
The network with the least number of encoding units that
achieves the reconstruction error of 1% or less is preferred.
The encoding vectors represent EHR data in a compressed
and continuous vector, suitable for any clustering technique.
For comparison, we evaluated other methods with local
(Local Linear Embedding (LLE) [8]) and global neighbor
algorithms (Isometric Mapping (ISOMAP) [9]); as well as
affinity matrix algorithms, such as Spectral Embedding [10]
and Multidimensional Scaling (MDS) [11].
4) Clustering: Without loss of generality, we used K-
means to conduct the final cluster analysis.
C. Simulation Setup and Experiments
First, we simulated a baseline scenario where all parame-
ters were set to an ideal level with complete, free of noise,
d = 10, 5000 samples per cluster, and m = 10. An effect size
of 10 resulted in less than 0.01% overlap between clusters,
TABLE I: Simulation experiments with default parameters
p = 0, η = 0, d = 10, n = 5000, and m = 10.
Experiment Parameter Levels
Effect Size d [3, 4, 5, 6, 7, 8]
Features m [6, 20, 40, 100, 200, 500]
Missingness (%) p [0, 10, 20, . . . , 80]
Noise η [4, 16, 64, 128, 256]
and heuristically m = 10 resulted in good performance
for all pipelines. This baseline was used to identify the
best performing pair of normalization and feature reduction
methods, which were then used in the rest of the experiments.
We then simulated four scenarios for testing the pipeline
robustness at various levels of severity. In all experiments,
we swept one simulation parameter while keeping all others
constant. We measured the adjusted rand-score [12], which
computes a similarity measure between the results of two sets
of labels by counting pairs that are assigned in the same or
different clusters in the predicted and true clusterings while
adjusting for random chance. Table I describes each exper-
imental setup and the default parameters. Every experiment
was run 5 times to extract the mean and standard deviation
of the performance.
1) Missingness: To simulate the missing entries in the
EHR, we randomly removed a percentage p, from the ob-
served data matrix and denoted them as missing values. We
varied p from 0 to 80% in increments of 10%.
2) Effect Size: We manipulated the effect size by varying
the distance between cluster centers, d. In two dimensions,
we can calculate the number of overlapped samples by
counting the number of samples beyond a distance of d2 in a
bivariate standard normal distribution. Then, in a triangular
setting, the number of overlapped samples would be 6
times the calculated amount. By conducting a Monte Carlo
simulation, we can convert the effect sizes of 3–8 to the
percentage of overlapped samples [13.35%, 4.55%, 1.24%,
0.27%, 0.04%, 0.01%]. This can be interpreted as the lower-
bound for error in cluster assignment.
3) Redundant Features: We assessed the robustness to
the number of redundant features present in the dataset by
increasing the dimensionality, m, while keeping the ground-
truth dimensionality of 2. We simulated projection matrices
that generated [6, 20, 40, 100, 200, 500] features.
4) Uninformative/Noisy Features: EHR data contain in-
formation that may not be useful in determining clusters of
similar patients. We assessed the effects of including non-
informative variables by appending η random continuous and
η random binary variables.
III. RESULTS
The baseline experiment revealed that the performance of
the clustering pipeline heavily depended on the choice of nor-
malization and feature reduction method (see Table II).DAE,
DnAE, and MDS paired best with Z-scoring, all with scores
above 0.99. ISOMAP performed best with Whitening while
LLE and Spectral Embedding obtained its best performance
when no scaling was used. We used these optimal pairs to
conduct the remainder of the experiments.
TABLE II: Baseline results for identifying best scaling for
each feature reduction method. The entries show average
score and standard deviation of the scores across repetitions.
MinMax Raw Whitening Z-score
DAE 0.982(0.03) 0.822(0.20) 0.841(0.15) 0.998(0.00)
DnAE 0.983(0.03) 0.769(0.20) 0.781(0.20) 0.998(0.00)
MDS 0.903(0.17) 0.985(0.03) 0.294(0.18) 0.999(0.00)
ISOMAP 0.264(0.41) 0.235(0.35) 0.822(0.26) 0.390(0.43)
LLE 0.737(0.20) 0.976(0.05) 0.503(0.32) 0.745(0.21)
Spec. Emb. 0.770(0.21) 0.994(0.01) 0.634(0.29) 0.753(0.23)
A. Robustness Experiments
1) Missingness: As shown in Fig. 1, levels of missingness
above 60% significantly impaired the clustering performance
for all pipeline configurations (all scores below 0.8). Among
the three imputation methods, MICE resulted in the best per-
formance for all feature reduction methods except ISOMAP,
for which KNN was marginally better up to 50%. Median
imputation consistently the worst performance.
2) Effect Size: As expected, the performance of all config-
urations increased with the effect size (Fig. 2a). Overall, the
top three performing feature reduction methods were LLE,
DAE, and MDS. LLE exhibited the best performance across
feature reduction methods but only marginally better than
DAE, e.g. the p-value of a paired t-test was 0.03 at the effect
size of 4.
3) Features: LLE, DAE, and MDS were essentially im-
mune to large amounts of redundant features (Fig. 2b).
DnAE appeared to be similarly immune at low levels, but
its performance sharply decreased with greater than 200
features. Conversely, Spectral Embedding benefited from
higher numbers of redundant features and performed on par
to the best methods for 200 and 500 redundant features.
ISOMAP performed poorly at all levels
4) Uninformative/Noisy Features: As shown in Fig. 2c,
most methods, except DnAE and ISOMAP, were immune to
large amounts of uninformative variables. DnAE was robust
to uninformative variables up to 32 continuous and binary
uninformative variables. ISOMAP did not tolerate even the
minimum number of uninformative variables.
B. Interaction Experiments
Following the robustness experiments, we identified DAE
and LLE as the top 2 best performing feature reduction
methods overall. To further compare these methods, we per-
formed subsequent experiments that allowed for interactions
of varying effect sizes, missingness, and noise.
Overall, LLE matched or outperformed DAE. In the effect
size vs noise experiment, (Fig. 3a) large amounts of unin-
formative variables and medium effect sizes favored LLE.
In the effect size vs missingness experiment, (Fig. 3b) LLE
showed significantly better performance for medium effect
sizes and low missingness and no difference for large effect
sizes and low to medium missingness.
IV. DISCUSSION
In the current paper, we propose and evaluate a cluster-
ing pipeline tailored for complex EHR data by comparing
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Fig. 2: Robustness experiments results
performances of commonly used techniques. We found two
pipelines that outperform other alternatives: 1) MICE imputa-
tion + LLE feature reduction; 2) MICE imputation + Z-score
normalization + DAE feature reduction. Both pipelines are
robust to missingness (up to 60%), uninformative noise and
large numbers of redundant features, while LLE performs
slightly better at smaller effect size. This is the first study to
present an unsupervised homogenization pipeline designed
for EHR clustering.
Normalization: EHR data are heterogeneous, containing
both categorical and continuous variables at different scales.
Normalization is recommended to reduce the variance among
variables. Most previous studies [2], [13], [14] normalized
EHR variables to a range of (0, 1), however, as shown in
Table II, the best normalization method is closely related
to the feature reduction method. For example, for DAE and
DnAE, Z-score normalization results in the best performing
pipelines, while no normalization is necessary for LLE.
This is reasonable since, unlike DAE and other distance-
based algorithms, neighbor-based algorithms, such as LLE,
eliminate the need to estimate distance between objects.
Imputation: Given the wide array of measurements that
can be obtained from patients, missing data are common,
and it is impossible that every patient has every possible
test and measurement. Physicians evaluate the cost-benefit
of each test and may not request a particular test if the
result will not be informative for the diagnosis or treatment.
We evaluated a spectrum of imputation techniques that could
induce different levels of artificial similarity. The simulation
results favored MICE for all feature reduction methods
except ISOMAP. Consistent with our studies, MICE has also
shown good performance for life-history/EHR datasets in
previous studies [15], [16].
The main assumptions of MICE are that other non-missing
values are predictive of the missing ones (redundancy) and
that the data are missing-at-random. EHR data satisfies the
redundancy assumption, for example, age, sex, and height
are known to be good predictors of aortic root diameter [17].
White et al. [18] note that MICE is sensitive to departures
from the missing-at-random assumption. However, such as-
sumptions can be relaxed as long as the dataset contains
enough complete samples to build reliable predictive models.
Theoretically, EHR data is likely to follow a missing not at
random over a missing at random mechanism, as there is
likely a reason for missing values (e.g. patients health, physi-
cians recommendation, socioeconomic status). However, the
true pattern of missingness is likely influenced by both MAR
and MNAR. Hence, MICE can still be applied given an
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Fig. 3: Interaction experiments. The gray areas denote where
neither method scored above 0.8, the white areas denote
no significant difference between score means. The colored
areas denote significant differences between LLE and DAE.
abundance of data.
Feature Reduction: The EHR contains many redundant
pieces of information. For example, body mass index can
be easily computed from height and weight. Thus, it is
necessary to reduce the redundancy to extract effective (and
possibly latent) features from this high dimensional dataset.
Our simulation results show that among the different feature
reduction methods, pipelines with DAE and LLE show the
highest accuracy. Moreover, LLE outperforms DAE by 0.05-
0.12 at medium effect size and high uninformative noise.
This suggests that LLE might be better at detecting gran-
ular phenotypes that have more overlapped samples (1-5%,
corresponding to an effect size of 4-5). Additionally, another
benefit of using LLE is that no normalization to input data
is needed, as discussed above.
However, compared to LLE, DAE is more computationally
efficient, that is O(m log(k)n log(n)) vs O(nm), where k
denotes the number of neighbors for LLE. Once the network
is trained, the weights can be applied to a new dataset
with minimal computation, while LLE computes and sorts
distances to all neighbors. Thus, considering the large-scale
nature of the EHR data, DAE might be a better choice
when used to make predictions for future patients. Recent
studies deep auto-encoders have demonstrated their ability
to identify meaningful representations of EHR data [13],
[14]. Miotto et al. first proposed the use of deep autoen-
coders for EHR data and called its representation “Deep
patient” [13]. They demonstrated its utility by assessing
the probability of patients developing various diseases and
showing improvement in classification scores for 76,214
patients and 78 different diseases. Similarly, Beaulieu-Jones
et al. reported improved classification scores for amyotrophic
lateral sclerosis diagnosis in clinical trials using 10,723
patients [14]. These are promising results which demonstrate
the potential of the proposed pipeline with DAE to utilize
EHR data to identify granular disease phenotypes, and to
ultimately facilitate precise diagnoses, risk prediction and
treatment strategies. Moreover, while these previous studies
have shown the promise of DAE, this is the first study to
validate and design the entire pipeline for clustering.
1) Conclusions: In conclusion, we propose an unsuper-
vised homogenization pipeline to fully integrate all com-
ponents of EHR data for clustering patients. After MICE
imputation, both LLE with raw features and DAE with z-
score normalization show good clustering results. While LLE
marginally outperformed DAE in several direct comparisons,
the computational efficiency of DAE in evaluating new
observations based on large- scale EHR data (as is desired
for precision medicine approaches) provides an important ad-
vantage. Future studies are required to evaluate and compare
the two pipelines in real clinical scenarios with large-scale
EHR data.
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